Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/17/25 16:55 | 4/15/25 | NUVL | Health | Drug | Pharmaceutical Preparations | Porter James Richard | MA | DO | P,CEO | 6 | M.d | 8,284 | 51.14 | 0 | 162 | 186 | 249 | D | ||||||||||||||
4/17/25 16:55 | 4/15/25 | NUVL | Health | Drug | Pharmaceutical Preparations | Porter James Richard | MA | DO | P,CEO | 6 | S.d | -8,284 | 51.14 | 0 | -162 | 249 | D | |||||||||||||||
3/28/25 16:45 | 3/27/25 | NUVL | Health | Drug | Pharmaceutical Preparations | Noci Darlene | MA | O | Chief De | 4 | M.dm | 2,887 | 37.99 | 0 | 76 | 48 | D | |||||||||||||||
3/28/25 16:45 | 3/27/25 | NUVL | Health | Drug | Pharmaceutical Preparations | Noci Darlene | MA | O | Chief De | 4 | S.dm | -2,887 | 37.99 | 0 | -76 | 48 | D | |||||||||||||||
2/25/25 16:49 | 2/24/25 | NUVL | Health | Drug | Pharmaceutical Preparations | Shair Matthew | MA | D | 2 | S | -322 | 80.61 | 0 | -4 | 0 | 1,646 | I | |||||||||||||||
2/4/25 16:46 | 1/31/25 | NUVL | Health | Drug | Pharmaceutical Preparations | Pelish Henry E. | MA | O | Chief Sc | 1 | M.d | 3 | 0.8699 | 0 | 3 | 5 | 63 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |